Gene therapy covers a broad spectrum of applications, from gene replacement and
knockdown for genetic or acquired diseases such as cancer, to vaccination, each with …

Drug delivery has been greatly improved over the years by means of chemical and physical
agents that increase bioavailability, improve pharmacokinetic and reduce toxicities. At the …

Drug delivery systems, particularly nanomaterial-based drug delivery systems, possess a
tremendous amount of potential to improve the diagnostic and therapeutic effects of drugs …

Erythrocytes are potential biocompatible vectors for different bioactive substances, including
drugs. These can be used successfully as biological carriers of drugs, enzymes and …

Peptide nucleic acids (PNA) are deoxyribonucleic acid (DNA) mimics with a pseudopeptide
backbone. PNA is an extremely good structural mimic of DNA (or of ribonucleic acid [RNA]) …

Carrier erythrocytes, resealed erythrocytes loaded by a drug or other therapeutic agents,
have been exploited extensively in recent years for both temporally and spatially controlled …

The use of a physiological carrier to deliver therapeutics throughout the body to both
improve their efficacy while minimising inevitable adverse side effects, is an extremely …

Although tremendous efforts have been made on targeted drug delivery systems, current
therapy outcomes still suffer from low circulating time and limited targeting efficiency. The …

Synthetic and biological vesicular carriers have been recognized as attractive and intelligent
systems for delivery of a verity of bioactive molecules. The importance of such delivery …

Immune cells can actively regulate tumors or inflammatory sites and have good
biocompatibility and safety. Currently, they are one of the most promising candidates for …